Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
15.14
+0.26 (1.75%)
At close: Jan 7, 2025, 4:00 PM
15.19
+0.05 (0.33%)
After-hours: Jan 7, 2025, 6:14 PM EST
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for BCYC stock have an average target of 35.25, with a low estimate of 17 and a high estimate of 60. The average target predicts an increase of 132.83% from the current stock price of 15.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BCYC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $32 → $26 | Buy | Maintains | $32 → $26 | +71.73% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $33 | Strong Buy | Maintains | $55 → $33 | +117.97% | Dec 16, 2024 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $28 → $17 | Hold | Maintains | $28 → $17 | +12.29% | Dec 13, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $25 | Hold | Initiates | $25 | +65.13% | Nov 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +131.18% | Nov 1, 2024 |
Financial Forecast
Revenue This Year
37.72M
from 26.98M
Increased by 39.81%
Revenue Next Year
30.04M
from 37.72M
Decreased by -20.36%
EPS This Year
-3.08
from -5.08
EPS Next Year
-3.60
from -3.08
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 45.7M | 63.0M | 145.1M | |||
| Avg | 37.7M | 30.0M | 50.7M | |||
| Low | 33.6M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 69.3% | 67.0% | 383.0% | |||
| Avg | 39.8% | -20.4% | 68.8% | |||
| Low | 24.4% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -2.97 | -3.12 | -2.82 | |||
| Avg | -3.08 | -3.60 | -4.05 | |||
| Low | -3.38 | -4.18 | -4.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.